Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Olive Oil and Cardiovascular Risk: The Higher the Consumption, the Lower the Risk?

High olive oil intake was associated with lower risk of coronary heart disease and cardiovascular disease in two large prospective cohorts of men and women.

Aceite de oliva y riesgo cardiovascular ¿A mayor consumo menos enfermedad?

The substitution of margarine, butter, mayonnaise, and dairy fat with olive oil can have a significant impact on cardiovascular health.

The benefits of olive oil intake have been well studied in Mediterranean populations. However, two factors should be considered: first, besides olive oil, that population consumes a whole combination of foods with cardiovascular benefit (a Mediterranean diet); second, the Mediterranean region is the main producer of olive oil and many feared a conflict of interests.

In that sense, we wondered about the effectiveness of this product in populations in other corners of the world.


Read also: Is There a “Safe” Dose for Meat Consumption?


This study assessed the eventual benefit of olive oil intake as regards overall cardiovascular disease, coronary heart disease, and stroke risk in an American population.

This study included 61,181 women and 31,797 men from 1990 to 2014 who were free of cancer, heart disease, and stroke at baseline. Diet was assessed through questionnaires at baseline and then every 4 years.

After 24 years of follow-up, adjusting for other risk factors, high olive oil intake (>0.5 tablespoon/day or >7 g/day) reduced the overall cardiovascular risk by 14% (hazard ratio [HR]: 0.86; 95% confidence interval [CI]: 0.79 to 0.94) and the coronary heart disease risk by 18% (HR: 0.82; 95% CI: 0.73 to 0.91), while there were no significant associations for total or ischemic stroke.


Read also: ACC Recommendations against the New Coronavirus.


Replacing 5 g/day of margarine, butter, mayonnaise, or dairy fat with the equivalent amount of olive oil reduces the total cardiovascular risk and the coronary heart disease risk by 5% to 7%.

The subset of participants with higher olive oil intake showed lower levels of circulating inflammatory biomarkers and a better lipid profile.

Conclusion

High olive oil intake was associated with a reduction in the risk of total cardiovascular and coronary heart disease. The substitution of margarine, butter, mayonnaise, and dairy fat with olive oil can have a clear benefit for cardiovascular health.

Título original: Olive Oil Consumption and Cardiovascular Risk in U.S. Adults.

Referencia: Marta Guasch-Ferré et al. Journal of the American College of Cardiology 2020, Journal Pre-proof. https://doi.org/10.1016/j.jacc.2020.02.036.


[wysija_form id=”3″]

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | P2Y12 Inhibitor Monotherapy After Complex PCI in ACS: Results From the NEO-MINDSET COMPLEX Subanalysis

This is a summary of the NEO-MINDSET COMPLEX subanalysis, presented by Dr. Guy Prado at EuroPCR 2026, which evaluated P2Y12 inhibitor monotherapy versus dual...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...